Joseph Paolillo

Oct 14, 2024 | jacc.org | Athar M. Qureshi |Robert Sommer |Gareth Morgan |Joseph Paolillo

IntroductionDevice closure of secundum atrial septal defects (ASDs) is considered the standard of care for the overwhelming majority of ostium secundum ASDs.1 Current devices approved by the U.S. Food and Drug Administration (FDA) include devices from the GORE (W. L.